Joel Michael Maryles serves as Executive at Chemomab Therapeutics Ltd., where they oversee executive responsibilities. Since joining the company, Joel Michael Maryles has executed 4 insider transactions totaling $5.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 24, 2022 involved purchasing 33 shares valued at $91.
Joel Michael Maryles currently holds 1,433 shares of Chemomab Therapeutics Ltd. (CMMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel Michael Maryles has been a net buyer of CMMB stock. They have purchased $5.6K and sold $0 worth of shares.
Joel Michael Maryles's most recent insider trade was on May 24, 2022, when they purchased 33 shares at $2.76 per share.
Get notified when new Form 4 filings are submitted
| $2.89 |
| Discretionary |
| Mar 18, 2022 | CMMB | $2.2K | Purchase | 500 | $4.32 | Discretionary |
| Mar 18, 2022 | CMMB | $2.2K | Purchase | 500 | $4.36 | Discretionary |